Clinical Trial Update: Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin [Phase 3]

View source ↗

Summary

Phase 3 trial comparing lixisenatide given before the main meal versus before breakfast in adults with type 2 diabetes on metformin; results were posted in 2016…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lixisenatide (lixisenatide)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2016-10-14